Back
Oculis Holding AG Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
23
OCS
Oculis Holding AG
Last Price:
11.95
Seasonality Move:
-6.1%
Sell
49
CRSP
CRISPR Therapeutics AG
Last Price:
49.60
Seasonality Move:
3.26%
Sell
23
Oculis Holding AG (OCS)
is a Sell
Is Oculis Holding AG a Buy, Sell or Hold?
- The current Oculis Holding AG [OCS] share price is $11.95. The Score for OCS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- OCS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $49.87. The Score for CRSP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCS Stock Price Chart
What is Oculis Holding AG's stock price today?
-
The Oculis Holding AG share price today is $11.95
The current trend is moderately bullish and OCS is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $49.87
The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.
OCS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 53.27 | Buy |
| Chaikin Money Flow: | -7873 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.83 - 12.05) | Buy |
| Bollinger Bands (100): | (11.52 - 12.22) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.8 | Sell |
| Relative Strength Index (14 RSI): | 55.84 | Buy |
| Chaikin Money Flow: | 789458 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.74 - 49.1) | Buy |
| Bollinger Bands (100): | (48.81 - 58.63) | Sell |
OCS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.97 | Sell |
| 20-day SMA: | 11.97 | Sell |
| 50-day SMA: | 11.73 | Buy |
| 200-day SMA: | 11.77 | Buy |
| 8-day EMA: | 11.96 | Sell |
| 20-day EMA: | 11.93 | Buy |
| 50-day EMA: | 11.84 | Buy |
| 200-day EMA: | 11.7 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.62 | Buy |
| 20-day SMA: | 47.21 | Buy |
| 50-day SMA: | 51.05 | Sell |
| 200-day SMA: | 60.95 | Sell |
| 8-day EMA: | 47.45 | Buy |
| 20-day EMA: | 47.57 | Buy |
| 50-day EMA: | 50.19 | Sell |
| 200-day EMA: | 56.4 | Sell |
Oculis Holding AG Earnings Growth & OCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.01 per share, an increase this year of $0.22 per share, and an increase next year of $0.25 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.
Oculis Holding AG Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||